scholarly article | Q13442814 |
P356 | DOI | 10.1002/AJH.2830480208 |
P698 | PubMed publication ID | 7847323 |
P2093 | author name string | J M Rowe | |
J F DiPersio | |||
N Blumberg | |||
J M Heal | |||
S A Kirkley | |||
A P Rapoport | |||
P433 | issue | 2 | |
P304 | page(s) | 108-115 | |
P577 | publication date | 1995-02-01 | |
P1433 | published in | American Journal of Hematology | Q4744246 |
P1476 | title | Leukodepleted-ABO-identical blood components in the treatment of hematologic malignancies: a cost analysis | |
P478 | volume | 48 |
Q35938500 | Clinical and economic impact of epoetins in cancer care |
Q34913728 | Inline-filtration |
Q35924467 | Lack of significant de novo HLA allosensitization in ventricular assist device recipients transfused with leukoreduced, ABO identical blood products |
Q33835138 | Leukocyte reduction of blood components: public policy and new technology |
Q33361167 | Optimizing platelet transfusion therapy |
Q45258025 | Randomized trial comparing packed red cell blood transfusion with and without leukocyte depletion for gastrointestinal surgery |
Q50600606 | The role and impact of the transfusion medicine consultation service in the management of patients in the hematopoietic transplant service: A retrospective analysis. |
Q53535347 | The second century of ABO: and now for something completely different. |
Q40945066 | Transfusion and stem cell support in cancer treatment |
Q36207276 | What would Karl Landsteiner do? The ABO blood group and stem cell transplantation |
Q33581238 | When less is more: cost-containment in transfusion medicine |
Search more.